臨床試験管理システム(CTMS)の世界市場2021年-2025年

◆英語タイトル:Global Clinical Trail Management System (CTMS) Market 2021-2025
◆商品コード:IRTNTR43269
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年3月18日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は世界の臨床試験管理システム(CTMS)市場規模が、2021年~2025年まで年平均11%成長し、601.90百万ドルに達すると予測しています。本調査レポートでは、世界の臨床試験管理システム(CTMS)市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別(製薬・バイオテクノロジー企業、CRO、その他)分析、顧客状況、地域別状況、企業状況、企業分析などをまとめております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の臨床試験管理システム(CTMS)市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、CRO、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Clinical Trail Management System (CTMS) Market 2021-2025
Technavio has been monitoring the clinical trail management system (CTMS) market and it is poised to grow by $ 601.90 million during 2021-2025, progressing at a CAGR of over 11% during the forecast period. Our reports on clinical trail management system (CTMS) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing healthcare expenditure, rise in clinical trials for drugs, and increased adoption of CTMS. In addition, the increasing healthcare expenditureis anticipated to boost the growth of the market as well.
The clinical trail management system (CTMS) market analysis includes the end-user segment and geography landscape.

Technavio’s clinical trail management system (CTMS) market is segmented as below:
By End-user
• Pharmaceutical and biotechnology companies
• CROs
• Others

By Geographic
• North America
• Europe
• Asia
• ROW

This study identifies the increasing outsourcing of clinical trial process as one of the prime reasons driving the clinical trail management system (CTMS) market growth during the next few years. Also, integration of CTMS with other systems and adoption of cloud computing will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on clinical trail management system (CTMS) market covers the following areas:
• Clinical trail management system (CTMS) market sizing
• Clinical trail management system (CTMS) market forecast
• Clinical trail management system (CTMS) market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trail management system (CTMS) market vendors that include ArisGlobal LLC, BioClinica Inc., Bio-Optronics Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., and Veeva Systems Inc. Also, the clinical trail management system (ctms) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/clinical-trial-management-system-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five Force Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Pharmaceutical and biotechnology companies – Market size and forecast 2020-2025
o CROs – Market size and forecast 2020-2025
o Others – Market size and forecast 2020-2025
o Market opportunity by End-user
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Volume driver
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o ArisGlobal LLC
o BioClinica Inc.
o Bio-Optronics Inc.
o Dassault Systemes SE
o DATATRAK International Inc.
o International Business Machines Corp.
o Medpace Holdings Inc.
o Oracle Corp.
o Parexel International Corp.
o Veeva Systems Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: End user – Market share 2020-2025 (%)
• 22: Comparison by End user
• 23: Pharmaceutical and biotechnology companies – Market size and forecast 2020-2025 ($ million)
• 24: Pharmaceutical and biotechnology companies – Year-over-year growth 2020-2025 (%)
• 25: CROs – Market size and forecast 2020-2025 ($ million)
• 26: CROs – Year-over-year growth 2020-2025 (%)
• 27: Others – Market size and forecast 2020-2025 ($ million)
• 28: Others – Year-over-year growth 2020-2025 (%)
• 29: Market opportunity by End user
• 30: Customer landscape
• 31: Market share by geography 2020-2025 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2020-2025 ($ million)
• 34: North America – Year-over-year growth 2020-2025 (%)
• 35: Europe – Market size and forecast 2020-2025 ($ million)
• 36: Europe – Year-over-year growth 2020-2025 (%)
• 37: Asia – Market size and forecast 2020-2025 ($ million)
• 38: Asia – Year-over-year growth 2020-2025 (%)
• 39: ROW – Market size and forecast 2020-2025 ($ million)
• 40: ROW – Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: ArisGlobal LLC – Overview
• 50: ArisGlobal LLC – Product and service
• 51: ArisGlobal LLC – Key offerings
• 52: ArisGlobal LLC – Key customers
• 53: ArisGlobal LLC – Segment focus
• 54: BioClinica Inc. – Overview
• 55: BioClinica Inc. – Product and service
• 56: BioClinica Inc. – Key offerings
• 57: BioClinica Inc. – Key customers
• 58: BioClinica Inc. – Segment focus
• 59: Bio-Optronics Inc. – Overview
• 60: Bio-Optronics Inc. – Product and service
• 61: Bio-Optronics Inc. – Key offerings
• 62: Bio-Optronics Inc. – Key customers
• 63: Bio-Optronics Inc. – Segment focus
• 64: Dassault Systemes SE – Overview
• 65: Dassault Systemes SE – Business segments
• 66: Dassault Systemes SE – Key offerings
• 67: Dassault Systemes SE – Key customers
• 68: Dassault Systemes SE – Segment focus
• 69: DATATRAK International Inc. – Overview
• 70: DATATRAK International Inc. – Business segments
• 71: DATATRAK International Inc. – Key offerings
• 72: DATATRAK International Inc. – Key customers
• 73: DATATRAK International Inc. – Segment focus
• 74: International Business Machines Corp. – Overview
• 75: International Business Machines Corp. – Business segments
• 76: International Business Machines Corp. – Key offerings
• 77: International Business Machines Corp. – Key customers
• 78: International Business Machines Corp. – Segment focus
• 79: Medpace Holdings Inc. – Overview
• 80: Medpace Holdings Inc. – Business segments
• 81: Medpace Holdings Inc. – Key offerings
• 82: Medpace Holdings Inc. – Key customers
• 83: Medpace Holdings Inc. – Segment focus
• 84: Oracle Corp. – Overview
• 85: Oracle Corp. – Business segments
• 86: Oracle Corp. – Key offerings
• 87: Oracle Corp. – Key customers
• 88: Oracle Corp. – Segment focus
• 89: Parexel International Corp. – Overview
• 90: Parexel International Corp. – Product and service
• 91: Parexel International Corp. – Key offerings
• 92: Parexel International Corp. – Key customers
• 93: Parexel International Corp. – Segment focus
• 94: Veeva Systems Inc. – Overview
• 95: Veeva Systems Inc. – Business segments
• 96: Veeva Systems Inc. – Key offerings
• 97: Veeva Systems Inc. – Key customers
• 98: Veeva Systems Inc. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

ArisGlobal LLC, BioClinica Inc., Bio-Optronics Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., Veeva Systems Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臨床試験管理システム(CTMS)の世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆